Analysts expect Enliven Therapeutics, Inc. to report revenue of 0.00 for Q2 26, against a range of 0.00 to 0.00. The most recent reported quarter, Q1 26, came in at 0.00.
| Metric | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | Q3 26 | Q4 26 | Q1 27 | Q2 27 | Q3 27 | Q4 27 | Q1 28 | Q2 28 | Q3 28 | Q4 28 | Q1 29 | Q2 29 | Q3 29 | Q4 29 | Q1 30 | Q2 30 | Q3 30 | Q4 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | - | - | - | - | - | - | - | - | |||||||||||
| High Estimate | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 13,517.13 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 766.78 | 1,104.19 | 1,067.53 | 3,764.37 | |||||||||||
| Low Estimate | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 12,484.11 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 699.72 | 955.13 | 955.87 | 3,492.51 | |||||||||||
| Consensus Estimate | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 13,000.62 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 733.25 | 1,029.66 | 1,011.70 | 3,628.44 |
Analysts expect Enliven Therapeutics, Inc. to report earnings per share of -0.40 for Q2 26, against a range of -0.43 to -0.37. The most recent reported quarter, Q1 26, came in at -0.38, a 7.3% beat against the -0.41 consensus.
| Metric | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | Q3 26 | Q4 26 | Q1 27 | Q2 27 | Q3 27 | Q4 27 | Q1 28 | Q2 28 | Q3 28 | Q4 28 | Q1 29 | Q2 29 | Q3 29 | Q4 29 | Q1 30 | Q2 30 | Q3 30 | Q4 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | -0.41 | -0.48 | -0.46 | -0.57 | -0.49 | -0.32 | -0.48 | -0.38 | - | - | - | - | - | - | - | - | |||||||||||
| High Estimate | -0.54 | -0.50 | -0.49 | -0.45 | -0.54 | -0.43 | -0.36 | -0.38 | -0.37 | -0.40 | -0.46 | -0.51 | -0.50 | -0.46 | -0.55 | -0.62 | |||||||||||
| Low Estimate | -0.60 | -0.54 | -0.57 | -0.49 | -0.58 | -0.47 | -0.38 | -0.44 | -0.43 | -0.46 | -0.54 | -0.55 | -0.54 | -0.50 | -0.65 | -0.76 | |||||||||||
| Consensus Estimate | -0.57 | -0.52 | -0.53 | -0.47 | -0.56 | -0.45 | -0.37 | -0.41 | -0.40 | -0.43 | -0.50 | -0.53 | -0.52 | -0.48 | -0.60 | -0.69 |